Clinical Trial Update: Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for EGFRm Resectable SIB-IIIA NSCLC. [Phase 4]

View source ↗

Summary

A ClinicalTrials.gov update describes a Phase 4 trial of combining osimertinib with chemotherapy for distant recurrence after adjuvant osimertinib in EGFR-mutan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Osimertinib (osimertinib)

Snippet

Sponsor: AstraZeneca | Conditions: Non-small Cell Lung Cancer | Phase 4 | Status: NOT_YET_RECRUITING